QVIDTVM Management LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
QVIDTVM Management LLC disclosed 8 US equity positions worth $124.2m in its Q4 2024 13F filing. The largest position was BIO at 31.5% of the reported book, followed by SOLV and RTO. Against the Q3 2024 filing, it opened 0 new positions, added to 3 and reduced 3 among the top 8 holdings.
What did QVIDTVM Management LLC own in Q4 2024? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | BIO BIO RAD LABS INC | Healthcare | 31.5% | $39.1m | 118,947 | -6% | reduced |
| 2 | SOLV SOLVENTUM CORP | Healthcare | 29.9% | $37.1m | 562,276 | 13% | added |
| 3 | RTO RENTOKIL INITIAL PLC | 13.2% | $16.4m | 649,176 | -13% | reduced | |
| 4 | BRCC BRC INC | 8.4% | $10.4m | 3,278,634 | 2% | added | |
| 5 | XRAY DENTSPLY SIRONA INC | Healthcare | 7.0% | $8.7m | 458,866 | 0% | held |
| 6 | WAB WABTEC | Industrials | 6.2% | $7.6m | 40,334 | -63% | reduced |
| 7 | ZGN ERMENEGILDO ZEGNA N V ORD SHS | Consumer Cyclical | 2.5% | $3.1m | 378,786 | 28% | added |
| 8 | SINGULAR GENOMICS SYSTEMS INC | 1.3% | $1.6m | 83,671 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.